Data Max


Investigating the Connection Between Hormonal Birth Control and Depression’s Latest Findings

Table of Contents

In my women's health practice, many patients have shared their experiences of feeling depressed while using hormonal birth control methods like the pill, patch, ring, implant, injection, or IUD. Surprisingly, this sentiment is not limited to my patients alone; even my friends have reported similar emotions. This alarming trend has prompted extensive research on the association between hormonal contraceptives and depression. While numerous studies have failed to establish a definitive link, a critical review has revealed the poor quality of the available literature, primarily relying on subjective methods such as self-reporting and insufficient sample sizes. Consequently, drawing firm conclusions about the connection between birth control and depression has remained elusive.

A High-Quality Study on Hormonal Birth Control and Depression

However, a study conducted in Denmark rises above the rest in terms of its high quality and credibility. This study examined the health records of over a million Danish women aged 14 and above, utilizing concrete data such as diagnosis codes and prescription records. Denmark's well-organized national health system facilitated this research by providing comprehensive and de-identified data on every individual in the country dating back to the 1970s. Additional information, such as education level, body mass index, and smoking habits, was also included. Astonishingly, this study uncovered unexpected connections between hormonal birth control and depression, shedding new light on the subject.

Methodology and Findings

Conducted between 2000 and 2013, this study focused on women aged 15 to 34 without preexisting psychiatric conditions. Participants with medical restrictions preventing them from using hormonal contraceptives, pregnant women, those within six months post-pregnancy, and recent immigrants were also excluded. The researchers analyzed the data in two ways: examining the incidence of diagnosed depression and the prescription of antidepressants. Remarkably, both analyses yielded statistically equivalent results.

The study revealed that all forms of hormonal contraception were associated with an increased risk of developing depression. Progesterone-only contraceptives, including the IUD, exhibited an even higher risk, particularly among teenagers aged 15 to 19. Notably, non-oral birth control methods like the ring, patch, and IUD were linked to a greater risk of depression. These findings challenge the long-standing belief that the IUD only acts locally and does not impact the rest of the body, highlighting the importance of reevaluating our understanding of its effects.

Weighing the Risks and Benefits

While it may be concerning to learn about the increased risk of depression associated with hormonal birth control, it is essential to assess the overall impact. The study indicates that approximately 2.2 out of 100 women using hormonal birth control developed depression, compared to 1.7 out of 100 who did not. Although the risk is elevated, it is important to note that only a small percentage of women are affected. However, identifying individuals who may be more susceptible to this side effect remains uncertain. As healthcare providers, it is crucial for us to discuss this possibility when counseling patients about birth control, just as we would counsel them about other potential risks such as blood clots and breast cancer. Ultimately, every medication carries inherent risks and benefits, and it is our responsibility to educate patients accordingly.

Unparalleled Research Opportunities in Denmark

The comprehensive data collection system in Denmark has played a pivotal role in facilitating studies like this. As a medical researcher, it amazes me how the availability of such inclusive and organized data allows for high-quality research. In contrast, in the United States, collecting and organizing such data across multiple medical offices, hospitals, and insurance companies is a significant challenge. Consequently, most of a researcher's efforts and funding often go towards data collection, making studies like the Danish one difficult to envision. It is truly a missed opportunity to not have a similar system in place here.

William H. McDaniel, MD

Dr. Robert H. Shmerling is the former clinical chief of the division of rheumatology at Beth Israel Deaconess Medical Center (BIDMC), and is a current member of the corresponding faculty in medicine at Harvard Medical School.

Leave a Comment

Scroll to Top